Nurix Therapeutics, NRIX
We recently published a list of 10 Worst ARK Stocks To Buy According to Short Sellers. In this article, we are going to take ...
Analyst Robert Burns from H.C. Wainwright reiterated a Buy rating on Nurix Therapeutics (NRIX – Research Report) and increased the price target ...
During the last three months, 9 analysts shared their evaluations of Nurix Therapeutics NRIX, revealing diverse outlooks from ...
GSA Capital Partners LLP lowered its position in shares of Nurix Therapeutics, Inc. (NASDAQ:NRIX – Free Report) by 58.7% ...
In this article, we are going to take a look at where Nurix Therapeutics, Inc. (NASDAQ:NRIX) stands against the other small-cap biotech stocks. The biotechnology sector is expanding quickly due to ...
Fintel reports that on December 6, 2024, BMO Capital initiated coverage of Nurix Therapeutics (NasdaqGM:NRIX) with a Outperform recommendation. As of December 3, 2024, the average one-year price ...
Nurix Therapeutics Presents Preclinical Data from Two Autoimmune and Inflammatory Disease Programs, NX-5948 and GS-6791, at ACR Convergence 2024 Data demonstrate potential superiority of a ...
H.C. Wainwright analyst Robert Burns raised the firm’s price target on Nurix Therapeutics (NRIX) to $35 from $30 and keeps a Buy rating on the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback